IGC Pharma, Inc. (IGC) stock
IGCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 2/309% above fair value
$0.18−0.01 (-4.61%)
Close on Nov 13, 2026Market cap $18.20MP/E –Yield –
IGC Pharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
IGC Pharma's price to book ratio was 3.3× on Nov 11, 2026, against 3.6× a year earlier. Over the last 5 years it ranged from 0.8× to 6.0×, with a median of 3.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.3× | +0.1 |
| 2025 | Dec 31, 2025 | 3.2× | −0.3 |
| 2024 | Dec 31, 2024 | 3.5× | +2.2 |
| 2023 | Dec 29, 2023 | 1.3× | +0.4 |
| 2022 | Dec 30, 2022 | 0.8× | −0.8 |
| 2021 | Dec 31, 2021 | 1.6× | −1.1 |
| 2020 | Dec 31, 2020 | 2.7× | +1.9 |
| 2019 | Dec 31, 2019 | 0.8× | +0.1 |
| 2018 | Dec 31, 2018 | 0.7× | +0.7 |
| 2017 | Dec 29, 2017 | 0.0× | +0.0 |
| 2016 | Dec 30, 2016 | 0.0× | +0.0 |
| 2015 | Dec 31, 2015 | 0.0× | −0.0 |
| 2014 | Dec 31, 2014 | 0.0× | −0.0 |
| 2013 | Dec 31, 2013 | 0.0× | −0.0 |
| 2012 | Dec 31, 2012 | 0.0× | – |
See a number that looks wrong?